Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.
D000818:Animals; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced*; D007051:Ibotenic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009281:Naphthalenes / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000502:physiology*; D010080:Oxazoles / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012686:Septal Nuclei / Q000502:physiology*; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
D009281:Naphthalenes; D010080:Oxazoles; D013764:Tetrahydronaphthalenes; D007051:Ibotenic Acid; C011639:ADTN; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; D012110:Reserpine; D004298:Dopamine